...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases.
【24h】

IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases.

机译:IGF-I诱导的少突胶质祖细胞增殖需要PI3K / Akt,MEK / ERK和Src样酪氨酸激酶。

获取原文
获取原文并翻译 | 示例

摘要

Insulin-like growth factor-I (IGF-I) is required for the growth of oligodendrocytes, although the underlying mechanisms are not fully understood. Our aim was to investigate the role of phosphatidylinositol 3-kinase (PI3K), mitogen-activated protein kinase kinase (MEK1), and Src family tyrosine kinases in IGF-I-stimulated proliferation of oligodendrocyte progenitors. IGF-I treatment increased the proliferation of cultured oligodendrocyte progenitors as determined by measuring incorporation of [(3)H]-thymidine and bromodeoxy-uridine (BrdU). IGF-I stimulated a transient phosphorylation of 3-phosphoinositide-dependent kinase-1 (PDK1) and extracellular signal-regulated kinases (ERK1/2) (targets of MEK1), as well as a rapid and sustained activation of Akt (a target of PI3K). Furthermore, inhibitors of PI3K (LY294002 and Wortmannin), MEK1 (PD98059 and U0126), and Src family tyrosine kinases (PP2) decreased IGF-I-induced proliferation, and blocked ERK1/2 activation. LY294002, Wortmannin and PP2 also blocked Akt activation. To further determine whether Akt is required for IGF-I stimulated oligodendrocyte progenitor proliferation, cultures were infected with adenovirus vectors expressing dominant-negative mutants of Akt or treated with pharmacological inhibitors of Akt. All treatments reduced IGF-I-induced oligodendrocyte progenitor proliferation. Our data indicate that stimulation of oligodendrocyte progenitor proliferation by IGF-I requires Src-like tyrosine kinases as well as the PI3K/Akt and MEK1/ERK signaling pathways.
机译:少突胶质细胞的生长需要胰岛素样生长因子-I(IGF-I),尽管其潜在机制尚不完全清楚。我们的目的是研究磷脂酰肌醇3-激酶(PI3K),促分裂原激活的蛋白激酶激酶(MEK1)和Src家族酪氨酸激酶在IGF-I刺激的少突胶质祖细胞增殖中的作用。通过测量[(3)H]-胸苷和溴脱氧尿苷(BrdU)的掺入,IGF-I处理增加了培养的少突胶质祖细胞的增殖。 IGF-I刺激了3-磷酸肌醇依赖性激酶1(PDK1)和细胞外信号调节激酶(ERK1 / 2)(MEK1的靶标)的瞬时磷酸化,以及Akt(Akt的靶标)的快速持续活化。 PI3K)。此外,PI3K(LY294002和Wortmannin),MEK1(PD98059和U0126)和Src家族酪氨酸激酶(PP2)的抑制剂可降低IGF-I诱导的增殖,并阻断ERK1 / 2活化。 LY294002,Wortmannin和PP2也阻断了Akt的活化。为了进一步确定IGF-I刺激的少突胶质细胞祖细胞增殖是否需要Akt,用表达Akt显性阴性突变体的腺病毒载体感染培养物或用Akt的药理抑制剂处理。所有治疗均降低了IGF-1诱导的少突胶质细胞祖细胞增殖。我们的数据表明,IGF-I刺激少突胶质细胞祖细胞增殖需要Src样酪氨酸激酶以及PI3K / Akt和MEK1 / ERK信号通路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号